MedPath

Vertanical GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

11

Active:5
Completed:4

Trial Phases

3 Phases

Phase 1:7
Phase 2:1
Phase 3:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials

Phase 1
7 (63.6%)
Phase 3
3 (27.3%)
Phase 2
1 (9.1%)

Efficacy and Safety of VER-01 in the Treatment of Patients With Chronic Low Back Pain

Phase 3
Not yet recruiting
Conditions
Chronic Low Back Pain
Interventions
Other: Placebo
First Posted Date
2025-05-02
Last Posted Date
2025-07-14
Lead Sponsor
Vertanical GmbH
Target Recruit Count
700
Registration Number
NCT06956014

Dose-Response Characterization of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain

Phase 2
Active, not recruiting
Conditions
Chronic Non-specific Low Back Pain
Interventions
Drug: Placebo
First Posted Date
2024-06-26
Last Posted Date
2025-05-20
Lead Sponsor
Vertanical GmbH
Target Recruit Count
652
Registration Number
NCT06475001
Locations
🇬🇧

St Pancras Clinical Research, London, United Kingdom

Comparison of VER-01 to Opioids in Patients With Chronic Non-specific Low Back Pain

Phase 3
Completed
Conditions
Chronic Non-specific Low Back Pain
Interventions
Drug: Opioid therapy
First Posted Date
2022-11-09
Last Posted Date
2024-11-25
Lead Sponsor
Vertanical GmbH
Target Recruit Count
384
Registration Number
NCT05610813
Locations
🇩🇪

Rheumazentrum Prof. Dr. med. Gunther Neeck, Bad Doberan, Germany

🇩🇪

Medizinische Hochschule Hannover (MHH), Hannover, Germany

Efficacy and Safety of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain

Phase 3
Completed
Conditions
Chronic Non-specific Low Back Pain
Interventions
Other: Placebo
First Posted Date
2021-06-28
Last Posted Date
2024-04-08
Lead Sponsor
Vertanical GmbH
Target Recruit Count
820
Registration Number
NCT04940741
Locations
🇩🇪

Emovis GmbH, Berlin, Germany

Food Effect Study of VER-01 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2021-06-18
Last Posted Date
2022-11-28
Lead Sponsor
Vertanical GmbH
Target Recruit Count
18
Registration Number
NCT04930796
Locations
🇦🇹

University of Medicine in Vienna - Department of Clinical Pharmacology, Vienna, Austria

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.